Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 5

Results For "IND"

5821 News Found

Sigachi Industries FY25 revenue surges 25%, EBITDA 46%
News | June 02, 2025

Sigachi Industries FY25 revenue surges 25%, EBITDA 46%

Newly commissioned MCC in Jhagadia and Dahej and CCS project expansions will unlock an additional 8,800 MTPA, fuelling year-over-year revenue gains of 20%-30% in excipients


USV’s ‘United for BP Control’ Mission takes aim at India’s blood pressure epidemic
Healthcare | May 29, 2025

USV’s ‘United for BP Control’ Mission takes aim at India’s blood pressure epidemic

The initiative was announced at World Hypertension Congress, Chennai


Granules India posts Q4 FY25 PAT at Rs. 152 Cr
News | May 28, 2025

Granules India posts Q4 FY25 PAT at Rs. 152 Cr

The company reported sustained increase in formulations' share despite slowdown in productivity of Gagillapur facility


Aurobindo Pharma Q4 PAT falls marginally to Rs. 903 Cr
News | May 27, 2025

Aurobindo Pharma Q4 PAT falls marginally to Rs. 903 Cr

During the quarter, US formulations revenue increased by 13.5 per cent YoY to Rs. 4,072 crore


Indoco Remedies receives final approval from the USFDA for Allopurinol Tablets USP
Drug Approval | May 24, 2025

Indoco Remedies receives final approval from the USFDA for Allopurinol Tablets USP

Allopurinol is used to prevent or lower high uric acid levels in the blood


Mankind Pharma posts Q4 FY25 consolidated PAT Rs. 425.11 Cr
News | May 22, 2025

Mankind Pharma posts Q4 FY25 consolidated PAT Rs. 425.11 Cr

The company has posted net profit of Rs. 1,986.43 crores for the Financial Year ended March 31, 2025


IICP and Indegene partner to enable more inclusive society
News | May 20, 2025

IICP and Indegene partner to enable more inclusive society

IICP is a registered charitable society working in the disability sector since 1974


Indraprastha Medical Corporation posts Q4 FY25 PAT at Rs. 41.01 Cr
News | May 18, 2025

Indraprastha Medical Corporation posts Q4 FY25 PAT at Rs. 41.01 Cr

Indraprastha Medical Corporation has reported total income of Rs. 340.10 crores during the period ended March 31, 2025


Abbott India posts Q4 FY25 net profit at Rs. 367.04 Cr
News | May 18, 2025

Abbott India posts Q4 FY25 net profit at Rs. 367.04 Cr

The company has posted net profit of Rs. 1,414.44 crores for the Financial Year ended March 31, 2025


Sanofi India posts 27% growth in operating profits in Q1 2025
News | May 16, 2025

Sanofi India posts 27% growth in operating profits in Q1 2025

Standalone profit from operations for the quarter were Rs. 162 crores